Reference: Sinning et al. AHJ Am Heart J 2012;164:102-110 Percutaneous aortic valve replacement (TAVI) is a novel technique for the treatment of severe aortic stenosis (SAS) that has been built with great enthusiasm in clinical practice, particularly in patients with excessive surgical risk. In these patients, a high obstructive peripheral vascular disease stands, a fact<a href="https://solaci.org/en/2012/10/01/tavi-more-risky-in-patients-with-peripheral-vascular-disease/" title="Read more" >...</a>